skb410
Small moleculeexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Jun 30, 2023 (NCT05906537)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07232602 | Phase 1/Phase 2 (Phase 2) | Dec 15, 2025 | Merck |
| NCT07222488 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2025 | Merck |
| NCT06818643 | Phase 1/Phase 2 (Phase 2) | Mar 24, 2025 | Merck |
| NCT05906537 | Phase 1 | Jun 30, 2023 | Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Merck | For profit | 3 | 3 | 1 | 2025 |
| Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. | For profit | 1 | 1 | 1 | 2023 |
2 organizations
Page 1 / 1